Esophagus

Papers
(The H4-Index of Esophagus is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study289
Role of modified Glasgow Prognostic Score in patients with achalasia who underwent laparoscopic Heller-myotomy with Dor-fundoplication127
Clinical predictors of special type of esophageal cancer90
Effectiveness of postoperative rehabilitation after discharge in survivors of esophageal or gastroesophageal junction cancers: a systematic review77
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional49
The safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma47
Multicenter retrospective analysis of complications and risk factors in endoscopic resection for esophageal cancer across Japan38
A nationwide survey on the safety of cricothyrotomy: a multicenter retrospective study in Japan34
Modification of the lesser curvature incision line enhanced gastric conduit perfusion as determined by indocyanine green fluorescence imaging and decreased the incidence of anastomotic leakage followi27
Comprehensive registry of esophageal cancer in Japan, 201626
Current status of prehabilitation before esophagectomy for patients with esophageal cancer among board-certified hospitals by the Japan Esophageal Society25
Esophagectomy for esophageal cancer in patients with a history of total pharyngolaryngectomy: a Japanese nationwide retrospective cohort study24
Novel endoscopic approaches using the endocytoscopy for the target biopsy in esophageal eosinophilia24
Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching20
Conversion surgery following immunochemotherapy for initially unresectable/recurrent esophageal cancer17
Outcomes of patients with esophageal squamous cell carcinoma who achieved a pathological complete response in the primary lesion by neoadjuvant treatment: a Japanese nationwide cohort study17
Comparison of anastomotic stricture rates between 23- and 25-mm powered circular staplers in cervical esophagogastric anastomosis: a propensity-matched study17
0.15114402770996